Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Клиническая характеристика 113 умерших пациентов с коронавирусной болезнью 2019 года: ретроспективное исследование
Tao Wang, Jianping Zhao, Chen Ding, Tao Chen, Ke Ma, Di Wu, Wei Guo, Hongwu Wang, Huilong Chen, Haijing Yu, Meifang Han, Shusheng Li, Xiaoping Luo, Qin Ning, Dong Xu, Jia Chen, Weiming Yan, Danlei Yang, Guang Chen, Xiaoping Zhang, Jiaquan Huang
2020-03-26

COVID-19 mortalityacute cardiac injuryacute respiratory distress syndromeclinical characteristicsretrospective case series
OBJECTIVE: To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. DESIGN: Retrospective case series. SETTING: Tongji Hospital in Wuhan, China. PARTICIPANTS: Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. Data were collected until 28 February 2020. MAIN OUTCOME MEASURES: Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection forms. RESULTS: The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). Male sex was more predominant in deceased patients (83; 73%) than in recovered patients (88; 55%). Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)). Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%). Patients with cardiovascular comorbidity were more likely to develop cardiac complications. Regardless of history of cardiovascular disease, acute cardiac injury and heart failure were more common in deceased patients. CONCLUSION: Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. Acute respiratory distress syndrome and respiratory failure, sepsis, acute cardiac injury, and heart failure were the most common critical complications during exacerbation of covid-19.
1
Deceased COVID-19 patients were older than recovered patients, with median ages of 68 versus 51 years, respectively.
2
Dyspnoea, chest tightness, and disorders of consciousness occurred more often in deceased patients; median time from symptom onset to death was 16 days.
3
Fatal cases frequently developed severe complications, including acute respiratory distress syndrome, sepsis, acute cardiac injury, heart failure, acute kidney injury, and hypoxic encephalopathy.
4
Leukocytosis and lymphopenia were markedly more prevalent among deceased patients, who also had higher liver, renal, muscle, cardiac, and coagulation biomarkers.
5
Male sex, chronic hypertension, and other cardiovascular comorbidities were substantially more frequent among deceased patients than recovered patients.

Patients with coronavirus disease 2019 (COVID-19) who died (deceased COVID-19 patients)

Clinical characteristics, laboratory abnormalities, disease progression, and complications associated with death compared with recovery

Publication Details
Publication Date
2020-03-26
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Tao Wang
Jianping Zhao
Chen Ding
Tao Chen
Ke Ma
Di Wu
Wei Guo
Hongwu Wang
Huilong Chen
Haijing Yu
Meifang Han
Shusheng Li
Xiaoping Luo
Qin Ning
Dong Xu
Jia Chen
Weiming Yan
Danlei Yang
Guang Chen
Xiaoping Zhang
Jiaquan Huang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%